Tavakoli, V., & Naing, S. (2017). JAK2 exon 12 mutation-positive myeloproliferative neoplasm associated with recurrent thromboembolism. Blood Res.
Chicago Style CitationTavakoli, Vahid, i Sundee Naing. "JAK2 Exon 12 Mutation-positive Myeloproliferative Neoplasm Associated With Recurrent Thromboembolism." Blood Res 2017.
Cita MLATavakoli, Vahid, i Sundee Naing. "JAK2 Exon 12 Mutation-positive Myeloproliferative Neoplasm Associated With Recurrent Thromboembolism." Blood Res 2017.
Atenció: Aquestes cites poden no estar 100% correctes.